日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy, safety, and biomarkers of neoadjuvant trastuzumab and pertuzumab combined with chemotherapy in Chinese patients with HER2-positive breast cancer: a multicenter retrospective cohort study

新辅助曲妥珠单抗和帕妥珠单抗联合化疗治疗中国HER2阳性乳腺癌患者的疗效、安全性和生物标志物：一项多中心回顾性队列研究

期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000003551
Qi, Xiaowei; Hu, Hong; Qiu, Pengfei; Chen, Wenlin; Wang, Xiaochun; Shi, Qiyun; Xu, Yan; Liu, Shu; Fang, Yanman; Li, Taolang; Ming, Jia; Zhou, Sihai; Chai, Fan; Liang, Yueyang; Fan, Yuanming; Tang, Peng; Chen, Li; Wang, Shushu; Jiang, Jun; Wang, Mengyuan; Zhang, Yi; Nie, Jianyun; Wang, Yongsheng
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Evaluating diagnostic efficacy of multigene testing in non-diagnostic thyroid nodules by fine-needle aspiration cytology: A prospective cohort study

评估多基因检测在细针穿刺细胞学检查无法确诊的甲状腺结节中的诊断效能：一项前瞻性队列研究

期刊:Chinese Journal of Cancer Research
影响因子:6.3
doi:10.21147/j.issn.1000-9604.2026.01.02
Zhang, Guozhi; Ren, Lin; Xiao, Jia; Bao, Yangqiu; Tian, Hao; Shi, Qiyun; Tang, Chunlin; Chen, Ping; Liang, Yan; Tang, Peng; Yan, Wenting; Zhang, Ye; Qi, Xiaowei; Guo, Yanli; Zhang, Yi
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Identification of key genes and immune infiltration mechanisms in limb ischemia-reperfusion injury: a bioinformatics and experimental study.

肢体缺血再灌注损伤中关键基因和免疫浸润机制的鉴定：生物信息学和实验研究

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1491928
Shi Qiyun, Tian Taotao, Li Yanfeng
免疫/内分泌
发表日期：2025
文献求助 收藏

The effect of rabbit skeletal muscle on the large segment autologous bone ectopic preconstruction of vascularized bone flap

兔骨骼肌对大段自体骨异位预重建血管化骨瓣的影响

期刊:Frontiers in Bioengineering and Biotechnology
影响因子:4.8
doi:10.3389/fbioe.2025.1639727
Li, Yanfeng; Zhou, Mingwu; Shi, Qiyun; Chen, Da
发表日期：2025
文献求助 收藏

Safety and efficacy of anlotinib combined with taxane and lobaplatin in neoadjuvant treatment of clinical stage II/III triple-negative breast cancer in China (the neoALTAL trial): a single-arm, phase 2 trial

在中国，安罗替尼联合紫杉烷类和洛铂新辅助治疗II/III期三阴性乳腺癌的安全性和有效性（neoALTAL试验）：一项单臂II期试验

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2024.102585
Liang, Yan; Liu, Jing; Ge, Jia; Shi, Qiyun; Zhang, Guozhi; Wan, Andi; Luo, Tao; Tian, Hao; Fan, Linjun; Wang, Shushu; Chen, Li; Tang, Peng; Zhu, Kai; Jiang, Jun; Bian, Xiuwu; Zhang, Yi; Qi, Xiaowei
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Two Hematological Markers Predicting the Efficacy and Prognosis of Neoadjuvant Chemotherapy Using Lobaplatin Against Triple-Negative Breast Cancer

两种血液学标志物预测洛铂新辅助化疗治疗三阴性乳腺癌的疗效和预后

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyae025
Wang, Cheng; Shi, Qiyun; Zhang, Guozhi; Wu, Xiujuan; Yan, Wenting; Wan, Andi; Xiong, Siyi; Yuan, Long; Tian, Hao; Ma, Dandan; Jiang, Jun; Qi, Xiaowei; Zhang, Yi
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Targeted multimodal synergistic therapy of drug-resistant HER2-positive breast cancer by pyrotinib-ICG self-assembled nanoparticles

利用吡咯替尼-ICG自组装纳米粒子靶向治疗耐药性HER2阳性乳腺癌的多模式协同疗法

期刊:American Journal of Cancer Research
影响因子:2.9
doi:10.62347/JZRN6919
Xuhong, Juncheng; Wu, Nisha; Shi, Qiyun; Tian, Hao; Peng, Zaihui; Jiang, Jun; Zhang, Jing; Qi, Xiaowei
肿瘤
HER2
肿瘤免疫
治疗耐药
乳腺癌
发表日期：2024
文献求助 收藏

Case Report: Four cases of SARS-CoV-2-associated Guillain-Barré Syndrome with SARS-CoV-2-positive cerebrospinal fluid detected by metagenomic next-generation sequencing: a retrospective case series from China

病例报告：中国回顾性病例系列研究：4例SARS-CoV-2相关格林-巴利综合征合并SARS-CoV-2脑脊液阳性病例，采用宏基因组二代测序技术检测：

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2023.1258579
Guan, Yalin; Yu, Changshen; Fei, Yunhan; Wang, Qiushi; Wang, Pan; Zuo, Wenchao; Wu, Hao; Qi, Xuemei; Shi, Qiyun
SARS-CoV-2
Sequencing
神经科学
发表日期：2023
文献求助 收藏

Pyrotinib-based therapeutic approaches for HER2-positive breast cancer: the time is now

基于吡咯替尼的HER2阳性乳腺癌治疗方法：时机已到

期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-023-01694-5
Qi, Xiaowei; Shi, Qiyun; Xuhong, Juncheng; Zhang, Yi; Jiang, Jun
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

Methylmalonic acid promotes colorectal cancer progression via activation of Wnt/β-catenin pathway mediated epithelial-mesenchymal transition

甲基丙二酸通过激活 Wnt/β-catenin 通路介导的上皮-间质转化促进结直肠癌进展

期刊:Cancer Cell International
影响因子:5.3
doi:10.1186/s12935-023-02973-z
Chunhua Hu #, Mujie Ye #, Jianan Bai #, Pengfei Liu, Feiyu Lu, Jinhao Chen, Ping Yu, Tiaotiao Chen, Xiaoting Shi, Qiyun Tang
信号转导
肿瘤
肠癌
Wnt/β-Catenin
发表日期：2023
文献求助 收藏